NCT04807283View on ClinicalTrials.gov

Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System

NAActive, not recruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

November 26, 2021

Study Completion Date

December 31, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

Left Atrial Appendage Closure

Closure or occlusion of the left atrial appendage to reduce the risk of thromboembolism in patients with NVAF

Trial Locations (4)

Unknown

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

Tbilisi Heart and Vascular Clinic, Tbilisi

Sanatorio Italiano Hospital, Asunción

Hospital de Clinicas San Lorenzo, National University, San Lorenzo

Sponsors

Lead Sponsor

Laminar, Inc.
All Listed Sponsors
lead

Laminar, Inc.

INDUSTRY